直 Japanese PDF Font
  • 我们的专业人员
  • 服务
  • 我们的见解
  • 办公室
  • 事务所
  • 人才招聘
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • 联邦巡回法院知识产权博客
    • INCONTESTABLE® Blog
    • Prosecution First博客
  • Events & Webinars
  • 知识产权讯息
  • 播客
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Webinar

Opportunities and Pitfalls: Preparing Your PTAB Case for Appeal to the Federal Circuit

December 4, 2014

Webinar

View Webinar

For two years, the Patent Trial and Appeal Board (PTAB) has conducted hundreds of patent trials, interpreting the meaning of the America Invents Act and developing trial rules for inter partes reviews and covered business method post-grant reviews. In these new trials, the PTAB has decided issues from claim construction to estoppel to the meaning of “covered business method patent.” Now it is the Federal Circuit’s turn to weigh in, as it faces an influx of appeals from PTAB decisions raising a host of issues of first impression. Join our panel of experts on PTAB trials and Federal Circuit appeals to learn about:

  • The Federal Circuit’s first rulings regarding potential review of the PTAB decision to institute trial, including St. Jude Medical, Cardiology Division, Inc. v. Volcano Corp. (Fed. Cir. 2014);
  • Early guidance from Consumer Watchdog v. Wisconsin Alumni Research Fund (Fed. Cir. 2014) on standing to appeal a PTAB decision to the Federal Circuit;
  • Strategic tips for conducting a PTAB trial with an eye to appeal; and
  • A look ahead to cases involving novel questions of law, the scope of PTAB authority, and the Federal Circuit’s role in resolving these issues.

Moderator:

Daniel C. Cooley

Speakers: 
Erika Harmon Arner 
Michael J. Flibbert

Date:
Thursday, December 4, 2014

Time:

1:00-2:00 pm EST

 

Downloadable Files

  • Webinar: Opportunities and Pitfalls: Preparing Your PTAB Case for Appeal to the Federal Circuit

Related Practices

全球知识产权维权、诉讼与审判

联邦巡回法院和最高法院上诉

Related Industries

医疗设备与诊断

数字医疗

消费品

生物技术

Related Professionals

Erika Harmon Arner
合伙人
Washington, DC
+1 571 203 2754
Email
Daniel C. Cooley
Partner
Reston, VA
+1 571 203 2778
Email
Michael J. Flibbert
Partner
Washington, DC
+1 202 408 4493
Email

Related Insights

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Webinar

Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement

May 18, 2026

Webinar

Federal Circuit IP Blog

When “and” and “e.g.” Matter: Federal Circuit Revives VLSI vs. Intel Case

May 14, 2026

Federal Circuit IP Blog

Federal Circuit Affirms § 102(b) Invalidity; Source Code Commands Are Not Hearsay

May 14, 2026

IP Updates

Tenth Circuit Sides with Netflix in Tiger King Copyright Challenge 

May 5, 2026

Conference

International Trade Commission Litigation & Enforcement

May 4-5, 2026

Washington, DC

Ad Law Buzz Blog

How to Survive a Section 230 Defense: Recent Cases Provide Guidance

May 1, 2026

Articles

Unpacking Squires’ Recent Discretionary Denial Guidance Focusing on American Manufacturing

April 24, 2026

Panel Discussion

2026 World IP Day Event – Women in Intellectual Property Law: Opportunities and Challenges

April 24, 2026

Virtual

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • 隐私
  • 免责申明
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP